Home/Directory/Contract Development & Manufacturing/BASF Pharma Solutions

BASF Pharma Solutions

Florham Park, NJ (US) · United States

Contract Development & Manufacturingmid

Specialization: Specialty Polymers & Excipients

Key Differentiator

Part of BASF SE (€68.9B revenue); Soluplus accepted into FDA excipient pilot program (Dec 2022); expanded Kollidon range for controlled-release biologics (Mar 2025); digital formulation tools (ZoomLab)

Core Services

Soluplus (solubility enhancement), Kollidon (binders/disintegrants), Kollicoat (coatings), Kolliphor (solubilizers), hot melt extrusion excipients, ZoomLab digital formulation tools

Capabilities

Soluplus (solubility enhancement)Kollidon (binders/disintegrants)Kollicoat (coatings)Kolliphor (solubilizers)hot melt extrusion excipientsZoomLab digital formulation tools

Market Intelligence

Pharma excipients market: $8.85B (2024) → $14.77B (2032), CAGR 6.6%; North America = 39.8% share

Website

https://pharma.basf.com

Similar Companies

AGC Biologics

Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·

Proprietary CHEF1® expression system

ARSI Canada Inc.

Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development

Mississauga CRO

Actylis (Montreal Operations)

Quebec ·

Global API and excipient supplier with Canadian manufacturing

Ajinomoto Bio-Pharma Services

San Diego, CA; Oss, Netherlands ·

Proprietary AJICAP™ site-specific ADC bioconjugation technology

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.